Precision medicine through comprehensive molecular profiling
NantOmics, founded in 2013 by Patrick Soon-Shiong and part of the NantWorks ecosystem, is a leader in molecular diagnostic testing based in Culver City, California. The company was the first to employ an integrated panomic approach to inform personalized treatment options for cancer patients. Its platform combines whole genome DNA sequencing, RNA sequencing, and quantitative proteomics, delivering actionable molecular profiles matched to targeted therapies. NantOmics' knowledge database spans hundreds of oncogenes and thousands of cellular pathways.